191 related articles for article (PubMed ID: 33055462)
21. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly.
Honkanen PO; Keistinen T; Kivelä SL
Arch Intern Med; 1996 Jan; 156(2):205-8. PubMed ID: 8546555
[TBL] [Abstract][Full Text] [Related]
22. Safety of concomitant administration of 23-valent polysaccharide pneumococcal vaccine and influenza vaccine among the elderly.
Won H; Kim JA; Jeong NY; Choi NK
Vaccine; 2024 May; 42(13):3190-3196. PubMed ID: 38641496
[TBL] [Abstract][Full Text] [Related]
23. Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study.
Jaeger VK; Hoffman HM; van der Poll T; Tilson H; Seibert J; Speziale A; Junge G; Franke K; Vritzali E; Hawkins PN; Kuemmerle-Deschner J; Walker UA
Rheumatology (Oxford); 2017 Sep; 56(9):1484-1491. PubMed ID: 28482054
[TBL] [Abstract][Full Text] [Related]
24. Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study.
Brooks WA; Chang LJ; Sheng X; Hopfer R;
Vaccine; 2015 Aug; 33(36):4610-7. PubMed ID: 26143615
[TBL] [Abstract][Full Text] [Related]
25. Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients.
Ranieri R; Veronelli A; Santambrogio C; Pontiroli AE
AIDS Res Hum Retroviruses; 2005 May; 21(5):407-9. PubMed ID: 15929703
[TBL] [Abstract][Full Text] [Related]
26. Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial.
Kivitz AJ; Schechtman J; Texter M; Fichtner A; de Longueville M; Chartash EK
J Rheumatol; 2014 Apr; 41(4):648-57. PubMed ID: 24584918
[TBL] [Abstract][Full Text] [Related]
27. Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study.
Mahamat A; Daurès JP; de Wzieres B
Hum Vaccin Immunother; 2013 Jan; 9(1):128-35. PubMed ID: 23442587
[TBL] [Abstract][Full Text] [Related]
28. Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study.
Leroux-Roels G; Maes C; De Boever F; Traskine M; Rüggeberg JU; Borys D
Vaccine; 2014 Nov; 32(50):6838-46. PubMed ID: 24607003
[TBL] [Abstract][Full Text] [Related]
29. Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers.
Gilchrist SA; Nanni A; Levine O
Am J Public Health; 2012 Apr; 102(4):596-605. PubMed ID: 22397339
[TBL] [Abstract][Full Text] [Related]
30. [New ideas on the therapeutic effect of a combination of vaccines against pneumococcal, Haemophilus influenzae type b infection, and influenza in patients with chronic obstructive pulmonary disease].
Kostinov MP; Zhestkov AV; Protasov AD; Magarshak OO; Kostinova TA
Ter Arkh; 2015; 87(3):17-22. PubMed ID: 26027235
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ⩾60-year-old adults.
Song JY; Cheong HJ; Hyun HJ; Seo YB; Lee J; Wie SH; Choi MJ; Choi WS; Noh JY; Yun JW; Yun JG; Kim WJ
Vaccine; 2017 Jan; 35(2):313-320. PubMed ID: 27919632
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of pneumococcal and influenza vaccination coverage in rheumatology patients receiving biological therapy in a regional referral hospital.
Fernández-Prada M; Brandy-García AM; Rodríguez-Fonseca OD; Huerta-González I; Fernández-Noval F; Martínez-Ortega C
Reumatol Clin (Engl Ed); 2020; 16(2 Pt 1):97-102. PubMed ID: 29752214
[TBL] [Abstract][Full Text] [Related]
33. Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia.
McManus M; Frangoul H; McCullers JA; Wang L; O'Shea A; Halasa N
Pediatr Blood Cancer; 2014 May; 61(5):815-20. PubMed ID: 24249544
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal non-typeable Hemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered with the DTPw-HBV/Hib vaccine in Indian infants: a single-blind, randomized, controlled study.
Lalwani S; Chatterjee S; Chhatwal J; Verghese VP; Mehta S; Shafi F; Borys D; Moreira M; Schuerman L
Hum Vaccin Immunother; 2012 May; 8(5):612-22. PubMed ID: 22634448
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants in Japan.
Togashi T; Yamaji M; Thompson A; Giardina PC; Aizawa M; Patterson S; Gruber WC; Scott DA;
Pediatr Infect Dis J; 2013 Sep; 32(9):984-9. PubMed ID: 23538524
[TBL] [Abstract][Full Text] [Related]
36. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older.
Jackson LA; Gurtman A; van Cleeff M; Frenck RW; Treanor J; Jansen KU; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
Vaccine; 2013 Aug; 31(35):3594-602. PubMed ID: 23688525
[TBL] [Abstract][Full Text] [Related]
37. Adverse reactions to simultaneous influenza and pneumococcal conjugate vaccinations in children: randomized double-blind controlled trial.
Jansen AG; Sanders EA; Smulders S; Hoes AW; Hak E
Pediatr Allergy Immunol; 2008 Sep; 19(6):552-8. PubMed ID: 18221474
[TBL] [Abstract][Full Text] [Related]
38. [Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study].
Wen Y; He L; Zhai Y; Wu J; Chen YY; Wang H; Zong QQ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):792-798. PubMed ID: 29936749
[No Abstract] [Full Text] [Related]
39. Cost-Effectiveness Analysis of Pneumococcal and Influenza Vaccines Administered to Children Less Than 5 Years of Age in a Low-Income District of Bogota, Colombia.
Lara C; De Graeve D; Franco F
Value Health Reg Issues; 2018 Dec; 17():21-31. PubMed ID: 29626706
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine.
Bryant KA; Frenck R; Gurtman A; Rubino J; Treanor J; Thompson A; Jones TR; Sundaraiyer V; Baxter LM; Gruber WC; Emini EA; Scott DA; Schmoele-Thoma B
Vaccine; 2015 Oct; 33(43):5854-5860. PubMed ID: 26362099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
